Chemotherapeutic dihydromyricetin with remarkable anti-tumor activity and biosafety for muscle invasive bladder cancer. Guo Z, Wang W, Hu W, You W, et al. Front Pharmacol 2025;16:1609354.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guo Z, Wang W, Hu W, You W, et al. Chemotherapeutic dihydromyricetin with remarkable anti-tumor activity and biosafety for muscle invasive bladder cancer. Front Pharmacol 2025;16:1609354.
PMID: 40756986